Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis

被引:109
作者
Psathakis, K
Mermigkis, D
Papatheodorou, G
Loukides, S
Panagou, P
Polychronopoulos, V
Siafakas, NM
Bouros, D
机构
[1] Army Gen Hosp Athens, Dept Pneumonol, Athens 11474, Greece
[2] Army Gen Hosp Athens, Clin Res Unit, Athens 11474, Greece
[3] Sismanogl Hosp Athens, Dept Pneumonol 3, Athens, Greece
[4] Univ Crete, Dept Pneumonol, Univ Hosp Herakl, Sch Med, Iraklion, Greece
[5] Univ Thrace, Sch Med, Univ Hosp Alexandroupolis, Alexandroupolis, Greece
关键词
8-isoprostane; expired breath condensate; H2O2; IPF; oxidative stress;
D O I
10.1111/j.1365-2362.2006.01636.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Expired breath condensate (EBC) has never been used to explore the level of oxidative stress in idiopathic pulmonary fibrosis (IPF). Therefore, the aim of this study was to measure the levels of H2O2 and 8-isoprostane, as biomarkers of oxidative stress, in the EBC of patients with IPF. Materials and methods We investigated 16 patients with IPF and 15 healthy subjects as the control group. The levels of H2O2 and 8-isoprostane were measured in the EBC of all subjects and were compared between the IPF and control groups. In patients with IPF, H2O2 and 8-isoprostane were further correlated with pulmonary function tests (PFTs), the resting pO(2) and the differential cell count from the bronchoalveolar lavage fluid (BALF). Results The mean (95%CI) concentration of H2O2 was increased in the patients with IPF compared with the normal subjects (0.36, 0.24-0.47 mu M vs. 0.16, 0.10-0.23 mu M, P = 0.003). The mean (95%CI) concentration of 8-isoprostane was also increased in the patients with IPF compared with the controls (74, 38-110 pg mL(-1) vs. 33, 28-39 pg mL(-1), P = 0.02). In the patients with IPF, the diffusing capacity of the lung for carbon monoxide was negatively correlated with the levels of H2O2 in EBC (P = 0.03, r = -0.58). No other correlation was found between the oxidative stress markers in the EBC and PFT values, pO(2) or BALF cell count. Conclusions Our data suggest that H2O2 and 8-isoprostane are increased in the EBC of patients with IPF. H2O2 may be correlated with the severity of the disease in IPF.
引用
收藏
页码:362 / 367
页数:6
相关论文
共 29 条
[1]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[2]   High-dose acetylcysteine in idiopathic pulmonary fibrosis [J].
Demedts, M ;
Behr, J ;
Buhl, R ;
Costabel, U ;
Dekhuijzen, R ;
Jansen, HM ;
MacNee, W ;
Thomeer, M ;
Wallaert, B ;
Laurent, F ;
Nicholson, AG ;
Verbeken, EK ;
Verschakelen, J ;
Flower, CDR ;
Capron, F ;
Petruzzelli, S ;
De Vuyst, P ;
van den Bosch, JMM ;
Rodriguez-Becerra, E ;
Corvasce, G ;
Lankhorst, I ;
Sardina, M ;
Montanari, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (21) :2229-2242
[3]  
GALLATI H, 1985, J CLIN CHEM CLIN BIO, V23, P453
[4]   Total nitrite/nitrate in expired breath condensate of patients with asthma [J].
Ganas, K ;
Loukides, S ;
Papatheodorou, G ;
Panagou, P ;
Kalogeropoulos, N .
RESPIRATORY MEDICINE, 2001, 95 (08) :649-654
[5]   Exhaled breath condensate:: methodological recommendations and unresolved questions [J].
Horvath, I ;
Hunt, J ;
Barnes, PJ ;
Alving, K ;
Antczak, A ;
Balint, B ;
Baraldi, E ;
Becher, G ;
van Beurden, WJC ;
Blomberg, A ;
Corradi, M ;
Dekhuijzen, R ;
Dweik, RA ;
Dwyer, T ;
Effros, R ;
Erzurum, S ;
Freels, J ;
Gaston, B ;
Gessner, C ;
Goldman, M ;
Greening, A ;
Ho, LP ;
Hohfeld, JM ;
Jöbsis, Q ;
Kharitonov, SA ;
Kelly, F ;
Laskowski, D ;
Lehmann, C ;
Lindstrom, A ;
Loukides, S ;
Marlin, D ;
Montuschi, P ;
Olin, AC ;
Redington, AE ;
Reinhold, P ;
van Rensen, ELJ ;
Robbins, R ;
Rubinstein, I ;
Silkoff, P ;
Smith, HJ ;
Steinhaeusser, WR ;
Teague, WG ;
Toren, K ;
Vass, G ;
Vaughan, J ;
Vogelberg, C ;
Wirtz, H .
EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (03) :523-548
[6]   Antioxidant therapy for idiopathic pulmonary fibrosis [J].
Hunninghake, GW .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (21) :2285-2287
[7]   Hydrogen peroxide in exhaled air of healthy children: reference values [J].
Jobsis, Q ;
Raatgeep, HC ;
Schellekens, SL ;
Hop, WCH ;
Hermans, PWM ;
de Jongste, JC .
EUROPEAN RESPIRATORY JOURNAL, 1998, 12 (02) :483-485
[8]   Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment [J].
Khalil, N ;
O'Connor, R .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (02) :153-160
[9]  
KING TE, 2000, AM J RESP CRIT CARE, V161, P646
[10]   Oxidative stress in pulmonary fibrosis - A possible role for redox modulatory therapy [J].
Kinnula, VL ;
Fattman, CL ;
Tan, RJ ;
Oury, TD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (04) :417-422